Home 
Blogs Chief Editor Rob Wright
Blogs Chief Editor Rob Wright
As I perused recent news headlines, I was struck by the number of lawsuits in the pharmaceutical industry. Having been in the business for nearly 20 years, I am very familiar with the litigation game. Recent headlines have Pfizer suing Merck, Bayer settling with Onyx, and Teva and Baxter being held liable for hepatitis C…
Not too long ago I wrote about being rather inept when it comes to social media. I still don’t have a Facebook page, and I am not planning on starting one anytime soon. I am having way too much fun with LinkedIn to want to spread my time thinner with managing more than two social…
Throughout my career I have the opportunity to attend conferences, tradeshows, shareholder meetings and the like. What has always struck me is the dichotomy which exists in peoples’ presentation skills. Some are insanely great, akin to Steve Jobs. Others make you wonder, “What were they thinking having this person present?” At a recent show, I…
The other day I received a phone call from a CEO of a pharmaceutical company. During our conversation this person mentioned they were in the process of unloading a non-core asset. I asked for some more details and learned how companies often develop certain valuable technologies. These technologies may be core to a clinical trial…
IQPC’s 9th Annual Cold Chain & Temperature Management Global Forum is a conference focused on keeping pharmaceutical and biological products cool. However, the new technologies and networking opportunities available at this year’s event were downright hot! This year’s event took place at the Pennsylvania Convention Center in Philadelphia. I had the opportunity to meet with…
I recently read a story about industry support for continuing medical education (CME) dropping for the third consecutive year. To this I say, “Well it’s about time.” When I worked in the pharmaceutical industry, it never ceased to amaze me how medical institutions would limit access to drug company sales representatives and yet be the…
Sunday, 25 September 2011 21:00
Breast Cancer Vaccine - Holds Promise For Several Players
Written by Rob Wright
I came across a headline in one of my news feeds announcing the FDA clearing the way for RXi Pharmaceuticals to move forward with plans for final-stage testing of a cancer vaccine. This might not seem like big news. The headline was not very attention getting in my opinion — “RXi gets go-ahead for cancer…
Tuesday, 20 September 2011 21:00
Yo Adrian! – The Disruptive Innovation Event Was A Knockout
Written by Rob Wright
Philadelphia has a history of being the place where dreams become reality. Home to the signing of the U.S. Declaration of Independence and fictional boxing legend Rocky Balboa, Philly can now lay claim to yet another success — The Conference Forum’s Disruptive Innovation in Clinical Trials. Co-chair John Orloff, SVP global development and CMO, Novartis…
Monday, 19 September 2011 11:19
Clinical Data Management Award Presented At SCDM 2011 Annual Conference
Written by Rob Wright
The 2011 Society for Clinical Data Management (SCDM) conference wrapped up this past week in Baltimore. This year’s conference offered a variety of topics and preconference workshops of interest to clinical data management professionals. Dr. Gilles Gallant, VP of clinical oncology at Human Genome Sciences served as the conference’s keynote presenter getting the dual-track conference…
Researchers at the Medical College of Wisconsin in Milwaukee are developing virtual varmints for disease research. Daniel Beard, a computational biologist, refers to this as the "Virtual Physiological Rat" project. Apparently, virtual rats are being developed from data gathered from live rat experiments, offering researchers insight into the mix of genetic and environmental risk factors…
Editorial Board Blogs
-
Bringing Biotech to Boats at BIO World Congress
Bringing Biotech to Boats at BIO World Congress
At the 2013 BIO World Congress on Industrial Biotechnology in Montreal next month you’ll be able to see a Campion boat on the exhibit show floor. “What will a boat be doing on the show floor of an industrial biotech[…]
Source: BIOtechNow
-
Leadership Lesson: The Difference Between Google and Apple
Leadership Lesson: The Difference Between Google and Apple
Google and Apple are both highly esteemed brands. Both companies share many common traits which have contributed to their success, but there is one very big difference between the two – Google plays offense while Apple has recently settled for[…]
Source: N2Growth Blog
-
Only 12% of Public Biotechs are Profitable
Only 12% of Public Biotechs are Profitable
Of the 286 biotech companies trading on public exchanges today, 241 focus on drug development, a slight drop in numbers from last year.* Of these 241 in the biopharmaceutical space, only 28 (12%) had both a product on the market[…]
Source: BIOtechNow
-
The Conundrum Of Healthcare In India
The Conundrum Of Healthcare In India
On a daily basis, one can come across a story in the U.S. print or electronic media about the problems faced in this country around the increased number of overweight and obese Americans. These concerns are justified. Obesity is the[…]
Source: Drug Truths
-
The FDA Approval Of Merck’s Cholesterol Lowerer, Liptruzet, Doesn’t Help Its Credibility
The FDA Approval Of Merck’s Cholesterol Lowerer, Liptruzet, Doesn’t Help Its Credibility
Josh Bloom recently wrote a very provocative piece entitled: “How can Merck look itself in the mirror?” Bloom is concerned that this once greatly admired pharmaceutical company has lost its way by bringing to market the LDL cholesterol lowering drug,[…]
Source: Drug Truths
-
Careering around in Cheltenham!
Careering around in Cheltenham!
Careering around in Cheltenham! By Katrina Brockbank Last month I attended the Cheltenham Festivals “Careering Around” careers fair. Run by STEMNET (Science, Technology, Engineering and Mathematics network) the careers fair aimed to introduce young people to the professional opportunities that[…]
Source: Freeman Technology - Free Flow
-
How To Predict The Future
How To Predict The Future
By Mike Myatt, Chief Strategy Officer, N2growth
Life is just plain easier when you can see what’s ahead of you. Some leaders clearly have poor vision – their most polished skill seems to be running into brick walls. Other leaders[…]
Source: N2Growth Blog
-
The missing link?
The missing link?
The missing link? By Tim Freeman I recently attended the Arden House Conference (48th AAPS Annual Arden House Conference) which this year was focusing on advances in pharmaceutical material characterisation and their importance in the effective application of QbD. There[…]
Source: Freeman Technology - Free Flow
By A Web Design
